D-0333-2021 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0333-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Apr 1, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Apr 28, 2022). Affected quantity: Lot #IT119008B - (4,128 Bottles); Lot #IT20001A - (3,984 Bottles); Lot #IT20002B - (4.080 Bottles).

Recall details

Product Type
Drugs
Report Date
Apr 21, 2021
Initiation Date
Apr 1, 2021
Termination Date
Apr 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
Lot #IT119008B - (4,128 Bottles); Lot #IT20001A - (3,984 Bottles); Lot #IT20002B - (4.080 Bottles)

Product description

Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-282-30.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot #s: IT119008B, Exp 05/2021; IT120001A, IT120002A, Exp 12/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0333-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0333-2021. Report a data issue: hello@regdatalab.com.